Accueil/Actions/TFX

TFX

USD

Teleflex Incorporated Common Stock

$121.990+1.270 (1.052%)

Prix en Temps Réel

Healthcare

Medical Instruments & Supplies

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$120.720

Haut

$122.350

Bas

$121.200

Volume

0.50M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.4B

Industrie

Medical Instruments & Supplies

Pays

United States

Statistiques de Trading

Volume Moyen

0.92M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $118.7Actuel $121.990Haut $249.91

Actualités Connexes

12 juin 2025 · 10:29

GlobeNewswire

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

11 juin 2025 · 10:30

GlobeNewswire

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages